Optical sensor for determining a dialysis dose

US12178944B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12178944-B2
Application numberUS-202218564074-A
CountryUS
Kind codeB2
Filing dateMay 25, 2022
Priority dateMay 26, 2021
Publication dateDec 31, 2024
Grant dateDec 31, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A device for determining a dialysis efficiency/dialysis dose of an extracorporeal blood treatment process has a radiation source, a cuvette, a detection unit and a control unit. The radiation source emits radiation, the intensity of which is controlled by adjusting a current intensity applied to the radiation source. The cuvette is preferably provided with an inlet and outlet, and is penetrated by radiation emitted by the radiation source. The detection unit detects the intensity of the radiation after the radiation passes the cuvette. The control unit determines the dialysis efficiency/dialysis dose from the intensity detected by the detection unit. The control unit, which is connected to the radiation source and detection unit, reduces the intensity of the radiation by adjusting the current intensity during the extracorporeal blood treatment process at least once, based on a drop in concentration of substances excreted in the urine in the dialysis fluid.

First claim

Opening claim text (preview).

The invention claimed is: 1. A device for determining a dialysis efficiency/dialysis dose of an extracorporeal blood treatment with a radiation source, a cuvette, at least one detection unit and a regulation/control unit, wherein the radiation source is intended and configured to emit a radiation, the intensity of which is controlled/regulated by adjusting a current strength to which the radiation source is subjected, the cuvette is provided with a dialysis fluid inlet and a dialysis fluid outlet and is intended and configured to be penetrated by the radiation emitted by the radiation source, the detection unit is provided and adapted to detect, as a measurement detection unit, the intensity of the radiation after it has passed the cuvette, the regulation/control unit determines the dialysis efficiency/dialysis dose from the intensity of the radiation detected by the detection unit, wherein the regulation/control unit is connected to the radiation source and the detection unit and is provided and configured to reduce the intensity of the emitted radiation by adjusting the current strength over the time course of the extracorporeal blood treatment at least once, based on a decrease in a concentration of urinary substances in the dialysis fluid. 2. The device according to claim 1 , wherein the regulation/control unit is provided and configured to control the radiation source in such a way that the intensity of the radiation detected by the detection unit remains constant over the time course of the extracorporeal blood treatment. 3. The device according to claim 2 , wherein the current strength applied to the radiation source is evaluated/used for determining the dialysis efficiency/dialysis dose. 4. The device according to claim 3 , wherein the dialysis efficiency/dialysis dose is the Kt/V value, where K describes the clearance, t the therapy duration and V the patient-specific distribution volume of urea in the body, and the regulation/control unit is provided and configured to determine the dialysis efficiency/dialysis dose via the rule Kt/V=ln(I(t3)/I(t)), where I describes the current strength, t3 a fixed point in time and t the therapy duration. 5. The device according to claim 3 , wherein the dialysis efficiency/dialysis dose is the Kt/V value, where K describes the clearance, t the therapy duration and V the patient-specific distribution volume of urea in the body, and the regulation/control unit is provided and configured to determine the dialysis efficiency/dialysis dose via the rule Kt/V=−ln(−0.008*t+(I(t)/I(t3))+(4−3.5*(I(t)/I(t3))*UF/W, where I describes the current strength, t3 describes a fixed point in time, t describes the therapy duration, UF describes the ultrafiltration volume and W describes the weight of the patient. 6. The device according to claim 3 , wherein the current strength is normalized to a reference temperature value. 7. The device according to claim 1 , wherein the device comprises a further detection unit provided and configured to detect the intensity of the radiation emitted from the radiation source as a reference detection unit, wherein the course of therapy comprises at least one regulation phase and at least one measuring phase, wherein the regulation/control unit reduces the intensity of the emitted radiation over the time course of the extracorporeal blood treatment at least once in the regulation phase and the regulation/control unit controls the radiation source by adjusting the current strength in such a way that the intensity of the radiation detected by the reference detection unit remains constant during the measuring phase and the intensity of the radiation is evaluated at the measuring detection unit for determining the dialysis efficiency/dialysis dose during the measuring phase. 8. The device according to claim 7 , wherein the regulation phase and/or the measuring phase are triggered by therapy parameters. 9. The device according to claim 7 , wherein the regulation phase and the measuring phase are performed at defined times of the extracorporeal blood treatment. 10. The device according to claim 7 , wherein an opacity of the cuvette is determined by a ratio change between the intensity of the radiation detected at the measuring detection unit and the intensity of the radiation detected at the reference detection unit. 11. The device according to claim 1 , wherein the current strengths and the duration with which the radiation source is subjected to the current strengths are stored and a prediction of the lifetime of the radiation source is carried out via these stored values. 12. The device according to claim 1 , wherein the cuvette is arranged between the radiation source and the measuring detection unit.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12178944B2 cover?
A device for determining a dialysis efficiency/dialysis dose of an extracorporeal blood treatment process has a radiation source, a cuvette, a detection unit and a control unit. The radiation source emits radiation, the intensity of which is controlled by adjusting a current intensity applied to the radiation source. The cuvette is preferably provided with an inlet and outlet, and is penetrated…
Who is the assignee on this patent?
Braun Avitum Ag
What technology area does this patent fall under?
Primary CPC classification A61M1/1609. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).